Diabetes patients who used a zone model predictive control-based artificial pancreas system experienced an improved percent time at 70 to 140 mg/dL and at 70 to 180 mg/dL, and a reduced median glucose and glycemic variability, compared with those who used a sensor-augmented pump therapy, according to a study in Diabetes Care. Researchers used a cohort of 19 adults and found that artificial pancreas use was also associated with an improvement in overnight glycemic control.
Study: Zone-MPC-based artificial pancreas effective for diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.